Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Timothy Dyer
Lénaic Teyssédou
Mikhail Kalinichev
Roger Mills
Board:
Isaac Manke
Raymond Hill
Roger Mills
Jake Nunn
Vincent Lawton
Shareholding in %:
Addex Therapeutics Ltd. 23.93
Armistice Capital LLC 2.2
Jean-Philippe Rocher 1.38
NEA Management Co. LLC 2.34
New Leaf Venture Partners LLC 0.87
Raymond George Hill 0.74
Robert Lutjens 1.63
Timothy Dyer 9.14
UBS Asset Management Switzerland AG 0.75
Vincent M. Lawton 1.36
Freefloat 55.67
Address: 9, Chemin des Mines, Plan-les-Ouates, 1202 Genf
T: +41-22-884-15-55
F: +41-22-884-15-56
I: http://www.addextherapeutics.com
E: info@addextherapeutics.com